Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
NOS1AP is a novel molecular target and critical factor in TDP-43 pathology
NYGC ALS Consortium
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NOS1AP is a novel molecular target and critical factor in TDP-43 pathology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Novel Therapeutic Targets
100%
TAR DNA-binding Protein 43 (TDP-43)
100%
TDP-43 Pathology
100%
NOS1AP
100%
Nitric Oxide Synthase 1 Adaptor Protein
66%
HnRNP
50%
Human Patients
16%
Signaling Pathway
16%
Lines of Evidence
16%
Protein Expression
16%
New Therapeutic Strategies
16%
Associated Proteins
16%
Mouse Cortical Neurons
16%
Transcriptome Analysis
16%
Cryptic Exon
16%
Exon Inclusion
16%
Relevant Genes
16%
Amyotrophic Lateral Sclerosis
16%
Proteinopathy
16%
Unc-13
16%
Novel Disease
16%
Stathmin-2
16%
Deleted in Azoospermia
16%
NMDA Signaling
16%
Immunology and Microbiology
Transactive Response Dna Binding Protein-43
100%
TAR DNA Binding Protein
100%
Nitric Oxide Synthase
66%
Downregulation
33%
Signal Transduction
16%
Protein Expression
16%
Exon
16%
Gene Expression Assay
16%